Uri Weinberg, M.D., Ph.D.
Equibles does not estimate personal net worth.
Get an email with a short summary when NovoCure Ltd publishes a filing, an earnings call transcript or a press release.
Get NVCR alertsAbout Uri Weinberg, M.D., Ph.D.
NovoCure Ltd reported in an 8-K filed April 9, 2026 that Uri Weinberg, M.D., Ph.D. was appointed Chief Medical Officer, effective April 8, 2026. NovoCure Ltd is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at NovoCure Ltd includes Asaf Danziger (CEO and Board Member), David Hung (CEO and Board Member), Frank Leonard (CEO and Board Member) and 7 others.
“On April 8, 2026, NovoCure Limited (the "Company"), through one of its affiliates, modified the compensation of Uri Weinberg, M.D., Ph.D., a named executive officer of the Company, in connection with his appointment as Chief Medical Officer in addition to his role as Chief Innovation Officer of the Company.”
Affiliation history
-
NovoCure Ltd (NVCR)
SEC 8-K
Current2026-04-08–present
Company network
Leadership on record at NovoCure Ltd
- Asaf Danziger CEO, Board Member
- David Hung CEO, Board Member
- Frank Leonard CEO, Board Member
- William Vernon CEO, Board Member
- Kinyip Gabriel Leung Chairman, Board Member
- William Doyle Chairman, Board Member
- Christoph Brackmann CFO
- Jeryl Hilleman CFO, Board Member
- Kristin Stafford CFO, Chief Accounting Officer, Board Member
- Mukund Paravasthu COO